(lp0
S'Biocept to Present at The MicroCap Conference on April 4th in New York City PR Newswire  - Mar 31, 2017 SAN DIEGO, March 31, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces ...'
p1
aS'Biocept Appoints Michael Terry Senior Vice President Commercial Operations PR Newswire  - Feb 15, 2017 SAN DIEGO, Feb. 15, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces the&nbsp;...'
p2
aS"Biocept to Present at the 27th Annual Oppenheimer Healthcare Conference PR Newswire  - Mar 14, 2017 SAN DIEGO, March 15, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces ...Catalyst Pharma to offer Biocept's liquid biopsy test in late-stage LEMS study ... - Seeking Alpha"
p3
aS"Biocept Inc  Scores Blue Cross Texas, Up 100% Insider Financial - Jan 11, 2017 Biocept Inc  gained more than 77% during Tuesday's session this week, and is up more than 100% on last week's close, on news that the company has picked up a fresh round of insurance coverage for its lead biopsy product.Stock Update : Here's Why Biocept Inc Shares Jumped 60% - Smarter AnalystBiocept, Inc.  Closed last trading session at $1.81 - TopChronicle"
p4
aS'Biocept to Present at the 19th Annual BIO CEO and Investor Conference PR Newswire  - Jan 10, 2017 SAN DIEGO, Feb. 6, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the management of cancer patients, announces that President and CEO Michael W. Nall&nbsp;...'
p5
aS"Biocept's CEO Issues Letter to Stockholders PR Newswire  - Feb 9, 2017 SAN DIEGO, Feb. 9, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that&nbsp;...Biocept inks group purchasing deal with national health plan for liquid ... - Seeking AlphaBiocept  Stock: Gaining Big On CEO Letter - CNA Finance "
p6
aS"Biocept to Present at the 29th Annual ROTH Conference PR Newswire  - Mar 8, 2017 SAN DIEGO, March 8, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that&nbsp;...Biocept's  CEO Michael Nauman on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha"
p7
aS'Watching Shares of Biocept Inc  Rives Journal - 16 hours ago Keeping an eye on moving averages for Biocept Inc , the 50-day is 2.06, the 200-day is at 1.56, and the 7-day is 1.86.'
p8
aS'Biocept Appoints Timothy C. Kennedy as Chief Financial Officer and Senior Vice ... PR Newswire  - Jul 27, 2016 SAN DIEGO, July 27, 2016 /PRNewswire/ -- Biocept, Inc. , a molecular diagnostics company commercializing and developing biomarkers to improve the detection and treatment of cancer, announces the appointment of Timothy C. Kennedy&nbsp;...'
p9
aS'Biocept Announces Closing of $10 Million Public Offering of Common Stock and ... PR Newswire  - Oct 19, 2016 SAN DIEGO, Oct. 19, 2016 /PRNewswire/ -- Biocept, Inc. , a molecular diagnostics company commercializing and developing blood-based liquid biopsies to provide information to physicians to improve the diagnosis and treatment of cancer,&nbsp;...'
p10
a.